Histone Deacetylase 2 Suppresses Skeletal Muscle Atrophy and Senescence via NF-κB Signaling Pathway in Cigarette Smoke-Induced Mice with Emphysema

References

• Vanfleteren L, Spruit MA, Wouters EFM, Franssen FME. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respirat Med. 2016;4(11):911–924. doi:10.1016/S2213-2600(16)00097-7
   PubMed Web of Science ®Google Scholar
• Barreiro E, Gea J. Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13(3):297–311. doi:10.1177/1479972316642366
   PubMed Web of Science ®Google Scholar
• Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81–88. doi:10.1183/09031936.00104909
   PubMed Web of Science ®Google Scholar
• Degens H, Gayan-Ramirez G, van Hees HW. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am J Respir Crit Care Med. 2015;191(6):620–625. doi:10.1164/rccm.201410-1830PP
   PubMed Web of Science ®Google Scholar
• Simoes DCM, Vogiatzis I. Can muscle protein metabolism be specifically targeted by exercise training in COPD? J Thorac Dis. 2018;10(Suppl 12):S1367–s1376. doi:10.21037/jtd.2018.02.67
   PubMedGoogle Scholar
• Verreijen AM, Verlaan S, Engberink MF, Swinkels S, de Vogel-van den Bosch J, Weijs PJ. A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults: a double-blind randomized controlled trial. Am J Clin Nutr. 2015;101(2):279–286. doi:10.3945/ajcn.114.090290
   PubMed Web of Science ®Google Scholar
• Abdellaoui A, Préfaut C, Gouzi F, et al. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J. 2011;38(4):781–788. doi:10.1183/09031936.00167110
   PubMed Web of Science ®Google Scholar
• Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266–273. doi:10.1378/chest.12-2664
   PubMed Web of Science ®Google Scholar
• Jaitovich A, Barreiro E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. What we know and can do for our patients. Am J Respir Crit Care Med. 2018;198(2):175–186. doi:10.1164/rccm.201710-2140CI
   PubMed Web of Science ®Google Scholar
• Wilkinson DJ, Piasecki M, Atherton PJ. The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Res Rev. 2018;47:123–132. doi:10.1016/j.arr.2018.07.005
   PubMed Web of Science ®Google Scholar
• Plant PJ, Brooks D, Faughnan M, et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2010;42(4):461–471. doi:10.1165/rcmb.2008-0382OC
   PubMed Web of Science ®Google Scholar
• Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280(17):4294–4314. doi:10.1111/febs.12253
   PubMed Web of Science ®Google Scholar
• Hussain SN, Sandri M. Role of autophagy in COPD skeletal muscle dysfunction. J Appl Physiol. 2013;114(9):1273–1281. doi:10.1152/japplphysiol.00893.2012
   PubMed Web of Science ®Google Scholar
• Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab. 2014;307(6):E469–484. doi:10.1152/ajpendo.00204.2014
   PubMed Web of Science ®Google Scholar
• Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294(5547):1704–1708. doi:10.1126/science.1065874
   PubMed Web of Science ®Google Scholar
• Rom O, Reznick AZ. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Free Radic Biol Med. 2016;98:218–230. doi:10.1016/j.freeradbiomed.2015.12.031
   PubMed Web of Science ®Google Scholar
• Foletta VC, White LJ, Larsen AE, Leger B, Russell AP. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch. 2011;461(3):325–335. doi:10.1007/s00424-010-0919-9
   PubMed Web of Science ®Google Scholar
• Huang D, Ma Z, He Y, et al. Long-term cigarette smoke exposure inhibits histone deacetylase 2 expression and enhances the nuclear factor-κB activation in skeletal muscle of mice. Oncotarget. 2017;8(34):56726–56736. doi:10.18632/oncotarget.18089
   PubMedGoogle Scholar
• Bin Y, Xiao Y, Huang D, et al. Theophylline inhibits cigarette smoke-induced inflammation in skeletal muscle by upregulating HDAC2 expression and decreasing NF-κB activation. Am J Physiol Lung Cell Mol Physiol. 2019;316(1):L197–l205. doi:10.1152/ajplung.00005.2018
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan S, Yao H, Rahman I. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. Copd. 2009;6(4):291–297. doi:10.1080/15412550903049132
   PubMedGoogle Scholar
• Gong F, Miller KM. Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation. Mutat Res. 2013;750(1–2):23–30. doi:10.1016/j.mrfmmm.2013.07.002
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Histone deacetylase-2 and airway disease. Ther Adv Respir Dis. 2009;3(5):235–243. doi:10.1177/1753465809348648
   PubMedGoogle Scholar
• Tan C, Xuan L, Cao S, Yu G, Hou Q, Wang H. Decreased histone deacetylase 2 (HDAC2) in peripheral blood monocytes (PBMCs) of COPD patients. PLoS One. 2016;11(1):e0147380. doi:10.1371/journal.pone.0147380
   PubMed Web of Science ®Google Scholar
• Kim RY, Horvat JC, Pinkerton JW, et al. MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2. J Allergy Clin Immunol. 2017;139(2):519–532. doi:10.1016/j.jaci.2016.04.038
   PubMed Web of Science ®Google Scholar
• Singh T, Prasad R, Katiyar SK. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics. 2013;8(1):54–65. doi:10.4161/epi.23078
   PubMed Web of Science ®Google Scholar
• Korfei M, Skwarna S, Henneke I, et al. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis. Thorax. 2015;70(11):1022–1032. doi:10.1136/thoraxjnl-2014-206411
   PubMed Web of Science ®Google Scholar
• Yao H, Rahman I. Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD. Am J Physiol Lung Cell Mol Physiol. 2012;303(7):L557–L566. doi:10.1152/ajplung.00175.2012
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J. 2005;25(3):552–563. doi:10.1183/09031936.05.00117504
   PubMed Web of Science ®Google Scholar
• To M, Swallow EB, Akashi K, et al. Reduced HDAC2 in skeletal muscle of COPD patients. Respir Res. 2017;18(1):99. doi:10.1186/s12931-017-0588-8
   PubMedGoogle Scholar
• Gosker HR, Langen RC, Bracke KR, et al. Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure. Am J Respir Cell Mol Biol. 2009;40(6):710–716. doi:10.1165/rcmb.2008-0312OC
   PubMed Web of Science ®Google Scholar
• Caron AZ, Haroun S, Leblanc E, et al. The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice. BMC Musculoskelet Disord. 2011;12:185. doi:10.1186/1471-2474-12-185
   PubMed Web of Science ®Google Scholar
• Qiu SL, Duan MC, Liang Y, et al. Cigarette smoke induction of interleukin-27/WSX-1 regulates the differentiation of Th1 and Th17 cells in a smoking mouse model of emphysema. Front Immunol. 2016;7:553. doi:10.3389/fimmu.2016.00553
   PubMed Web of Science ®Google Scholar
• Mercado N, To Y, Ito K, Barnes PJ. Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ. J Pharmacol Exp Ther. 2011;337(2):465–470. doi:10.1124/jpet.110.175950
   PubMed Web of Science ®Google Scholar
• Debigaré R, Marquis K, Côté CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest. 2003;124(1):83–89. doi:10.1378/chest.124.1.83
   PubMed Web of Science ®Google Scholar
• Doucet M, Russell AP, Léger B, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(3):261–269. doi:10.1164/rccm.200605-704OC
   PubMed Web of Science ®Google Scholar
• Vogiatzis I, Simoes DC, Stratakos G, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J. 2010;36(2):301–310. doi:10.1183/09031936.00112909
   PubMed Web of Science ®Google Scholar
• Aversa Z, Zhang X, Fielding RA, Lanza I, LeBrasseur NK. The clinical impact and biological mechanisms of skeletal muscle aging. Bone. 2019;127:26–36. doi:10.1016/j.bone.2019.05.021
   PubMed Web of Science ®Google Scholar
• MacNee W. Is chronic obstructive pulmonary disease an accelerated aging disease? Ann Am Thorac Soc. 2016;13(Suppl 5):S429–s437. doi:10.1513/AnnalsATS.201602-124AW
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med. 2019;200(5):556–564. doi:10.1164/rccm.201810-1975TR
   PubMed Web of Science ®Google Scholar
• Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med. 2006;174(5):530–537. doi:10.1164/rccm.200511-1816OC
   PubMed Web of Science ®Google Scholar
• Wilting RH, Yanover E, Heideman MR, et al. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J. 2010;29(15):2586–2597. doi:10.1038/emboj.2010.136
   PubMed Web of Science ®Google Scholar
• Moresi V, Carrer M, Grueter CE, et al. Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. Proc Natl Acad Sci U S A. 2012;109(5):1649–1654. doi:10.1073/pnas.1121159109
   PubMed Web of Science ®Google Scholar
• Remels AH, Gosker HR, Langen RC, et al. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression. Biochim Biophys Acta. 2014;1842(2):175–185. doi:10.1016/j.bbadis.2013.11.001
   PubMed Web of Science ®Google Scholar
• Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol. 2005;37(10):1974–1984. doi:10.1016/j.biocel.2005.04.018
   PubMed Web of Science ®Google Scholar
• Cai D, Frantz JD, Tawa NE, et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004;119(2):285–298. doi:10.1016/j.cell.2004.09.027
   PubMed Web of Science ®Google Scholar
• Wei W, Ji S. Cellular senescence: molecular mechanisms and pathogenicity. J Cell Physiol. 2018;233(12):9121–9135. doi:10.1002/jcp.26956
   PubMed Web of Science ®Google Scholar
• Ding J, Li F, Cong Y, et al. Trichostatin A inhibits skeletal muscle atrophy induced by cigarette smoke exposure in mice. Life Sci. 2019;235:116800. doi:10.1016/j.lfs.2019.116800
   PubMed Web of Science ®Google Scholar